While you see both these with respect to cancer screening, I wanted to know the difference between the two to compare between interventions and survival.

Consider two groups A and B.

Group A: Receives treatment with A and then is followed until death.

Group B: Receives treatment with A. After several weeks receives treatment with B. And then followed until death.

Note: This is not a prospective randomized trial.

Now, an early death prevents a patient from getting B. Patients who died

quickly had less time available to get transplants and will be counted as group A. Is this (Time A to B) causing an immortal time bias or lead time bias?

More Kushal Naik's questions See All
Similar questions and discussions